connecting the academic and pharmaceutical
communities in the greater boston area
Merck Research Laboratories is proud to present the inaugural Boston Symposium on Organic and Bioorganic Chemistry September 27-28 at the MRL Boston research facility. This unique, two-day forum will provide an experience for attendees that includes:
- Keynote presentations from two of the Boston area's leading academic chemistry researchers.
Prof. Mohammad Movassaghi, Massachusetts Institute of Technology
Prof. Gregory L. Verdine, Harvard University
- Cutting-edge science presentations and poster sessions by local students and professional scientists from world-class academic and industrial institutions.
- Networking opportunities for students, faculty, and industry scientists.
- An exciting workshop designed specifically for students interested in understanding how a drug goes from concept to commercialization. The development of Isentress, the first integrase inhibitor approved for the treatment of HIV infection, will be described.
Join us in Boston September 27-28 for this extraordinary opportunity to learn about state-of-the-art research in the fields of organic and bioorganic chemistry and to network with your peers and industry and academic scientists.
Eric N. Jacobsen, Ph.D., Sheldon Emery Professor of Chemistry, Department of Chemistry & Chemical Biology, Harvard University
Rick Friesen, Ph.D., Executive Director and Discovery Chemistry Site Lead at MRL Boston